Merkel Cell Carcinoma


Merkel cell carcinoma, as first described by Toker, et al. (1) in 1972, and otherwise known as trabecular carcinoma of the skin, neuroendocrine carcinoma of the skin, cutaneous APUDoma, primary small cell carcinoma of the skin with endocrine differentiation, is an uncommon, aggressive cutaneous neoplasm. Friederich Merkel first discovered the Merkel cell in 1875. It is a large, clear, usually round or oval cell found in the basal layer of the epidermis. It is found in close association with terminal axons, and is joined to keratinocytes. They are found in highest concentrations in acral skin, namely the fingertips and nasal tip, as well as glabrous skin, hairy skin, and mucous membranes. The exact function of Merkel cells is unclear, but it is generally thought that they are a form of touch receptor (2–4). The origin of Merkel cell carcinoma is controversial as well. It may arise from epidermal Merkel cells, dermal neuroendocrine cells, or poorly differentiated epidermal stem cells.


Small Cell Carcinoma Neuroendocrine Carcinoma Merkel Cell Carcinoma Isolate Limb Perfusion Epidermal Stem Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105: 107–110.PubMedCrossRefGoogle Scholar
  2. 2.
    Freedberg RM, Eisen AZ, Wolff K, Austem KF, Goldsmith LA, Katz SI, Fitzpatrick TB. Fitzpatrick’s Dermatology in General Medicine, 5th ed., Vol. II. McGraw-Hill, 1999; 915–918, 1261, 2991.Google Scholar
  3. 3.
    Haag M, Glass LF, Fensek NA. Merkel cell carcinoma: Diagnosis and treatment. Dermatol Surg 1995; 21: 669–683.PubMedCrossRefGoogle Scholar
  4. 4.
    Kennedy MM, Blessing D, King G, et al. Expression of bcl-2 and p53 in Merkel cell carcinoma: An immunohistochemical study. Amer J Dermatopathol 1996; 18(3): 273–277.CrossRefGoogle Scholar
  5. 5.
    Schlagbauer-Wadl H, Klosner G, Heere-Ress, et al. Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice. J Invest Dermatol 2000; 114(4): 725–730.PubMedCrossRefGoogle Scholar
  6. 6.
    Feinmesser M, Halpern M, Fenig E, et al. Expression of the apoptosis-related oncogenes bcl-2, bax, and p53 in Merkel cell carcinoma: Can they predict treatment response and clinical outcome? Hum Pathol 1999; 30(11): 1367–1372.PubMedCrossRefGoogle Scholar
  7. 7.
    Su LD, Fullen DR, Lowe L, Uherova P, Schnitzer B, Valdez R. CD 117 (KIT Receptor) expression in Merkel cell carcinoma. Am J Dermatopathol 2002; 24(4): 289–293.PubMedCrossRefGoogle Scholar
  8. 8.
    Gollard R, Weber R, Kosty M, et al. Merkel cell carcinoma: Review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer 2000; 88(8): 1842–1851.PubMedCrossRefGoogle Scholar
  9. 9.
    Walsh N. Primary neuroendocrine (Merkel cell) carcinoma of the skin: Morphologic diversity and implications thereof. Hum Pathol 2001; 32(7): 680–689.PubMedCrossRefGoogle Scholar
  10. 10.
    Leech SN, Kolar AJO, Barrett PD, et al. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J Clin Pathol 2001; 54(9): 727–729.PubMedGoogle Scholar
  11. 11.
    Kontochristopoulos GJ, Stavropoulos PG, Krasagakis K, et al. Differentiation between Merkel cell carcinoma and malignant melanoma: An immunohistochemical study. Dermatol 2000; 201(2): 123–126.CrossRefGoogle Scholar
  12. 12.
    Cheuk W, Kwan MY, Suster S, et al. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 2001; 125: 229–231.Google Scholar
  13. 13.
    Wasserberg N, Feinmesser M, Schachter J, et al. Sentinelnode guided lymph node dissection for Merkel cell carcinoma. Eur J Surg Oncol 1999; 25(4): 444–446.PubMedCrossRefGoogle Scholar
  14. 14.
    Zeitouni N, Cheney R, Delacure M. Lymphoscintigraphy, sentinel lymph node biopsy, and Mohs micrographic surgery in the treatment of Merkel cell carcinoma. Dermatol Surg 2000; 26(1): 12–18.PubMedCrossRefGoogle Scholar
  15. 15.
    Rodrigues LKE, Leong SPL, Kashani-Sabet M, et al. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol 2001; 45(2): 303–308.PubMedCrossRefGoogle Scholar
  16. 16.
    Herbst A, Haynes HA, Nghiem P. The standard of care for Merkel cell carcinoma should include adjuvant radiation and lymph node surgery. J Am Acad Dermatol 2002; 46(4): 640–642.PubMedCrossRefGoogle Scholar
  17. 17.
    Ott M, Tanabe K, Gaad M, et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999; 134(4): 388–393.PubMedCrossRefGoogle Scholar
  18. 18.
    Brown TJ, Jackson BA, Macfarlane DF, et al. Merkel cell carcinoma: Spontaneous resolution and management of metastatic disease. Dermatol Surg 1999; 25(1): 23–25.PubMedCrossRefGoogle Scholar
  19. 19.
    Wasserberg N, Schachter J, Fenig E, et al. Applicability of the sentinel node technique to Merkel cell carcinoma. Dermatol Surg 2000; 26(2): 138–141.PubMedCrossRefGoogle Scholar
  20. 20.
    Boyer JD, Zitelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: Review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002; 47(6): 885–892.PubMedCrossRefGoogle Scholar
  21. 21.
    Gibbs P, Gonzalez R, Lee L, Walsh P. Medical management of cutaneous malignancies. Clinics Dermatol 2001; 19(3): 298–304.CrossRefGoogle Scholar
  22. 22.
    Yazijii H, Gown AM. Merkel cell carcinoma: Review of 22 cases with surgical, pathologic, and therapeutic considerations (letter; comment). Cancer 2000; 89(8): 1866–1867.CrossRefGoogle Scholar
  23. 23.
    Connelly TJ, Cribier B, Brown TJ, et al. Complete spontaneous regression of Merkel cell carcinoma: A review of the 10 reported cases. Dermatol Surg 2000; 26(9): 853–856.PubMedCrossRefGoogle Scholar
  24. 24.
    Duker I, Starz H, Bachter D, et al. Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma. Dermatol 2001; 202(3): 225–229.CrossRefGoogle Scholar
  25. 25.
    Messina JL, Reintgen DS, Cruse CW, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997; 4(5): 389–395.PubMedCrossRefGoogle Scholar
  26. 26.
    Waldmann V, Goldschmidt H, Jackel A, et al. Transient complete remission of metastasized Merkel cell carcinoma by high dose polychemotherapy and autologous peripheral blood stem cell transplantation. Brit J Dermatol 2000; 143(4): 837–839.CrossRefGoogle Scholar
  27. 27.
    Olieman A, Lienard D, Eggermont A, et al. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities. Arch Surg 1999; 134(3): 303–307.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Personalised recommendations